Pfizer starts study of oral drug for preventing COVID-19

Pfizer has started testing an oral antiviral pill aimed at preventing COVID-19 infections, the pharmaceutical company announced Monday.
The drug, PF-07321332, is designed to block the main enzyme the coronavirus needs to multiply, Pfizer said. PF-07321332 will be co-administered with a small dose of ritonavir, an antiviral that is used in combination with other medications to treat HIV.
"If successful, we believe this therapy could help stop the virus early — before it has had a chance to replicate extensively — potentially preventing symptomatic disease in those who have been exposed and inhibiting the onset of infection in others," Mikael Dolsten, Pfizer's chief scientific officer and president of worldwide research, development, and medical, said in a statement.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
This antiviral could not only help treat people who will not get vaccinated against COVID-19, but would also be beneficial in countries where they expect it will take several years to get all residents fully vaccinated, Axios notes.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Today's political cartoons - March 8, 2025
Cartoons Saturday's cartoons - trade wars, healthcare costs, and more
By The Week US Published
-
Marbled tea eggs recipe
The Week Recommends With a beautiful exterior, these eggs are also marked by their soft yolk
By The Week UK Published
-
The Washington Post: kowtowing to Trump?
Talking Point The newspaper's opinion editor has handed in his notice following edict from Jeff Bezos
By The Week UK Published
-
Why some people remember dreams and others don't
Under The Radar Age, attitude and weather all play a part in dream recall
By Chas Newkey-Burden, The Week UK Published
-
Pharaoh's tomb discovered for first time in 100 years
Speed Read This is the first burial chamber of a pharaoh unearthed since Tutankhamun in 1922
By Peter Weber, The Week US Published
-
Scientists report optimal method to boil an egg
Speed Read It takes two temperatures of water to achieve and no fancy gadgets
By Peter Weber, The Week US Published
-
Europe records big leap in renewable energy
Speed Read Solar power overtook coal for the first time
By Peter Weber, The Week US Published
-
Blue Origin conducts 1st test flight of massive rocket
Speed Read The Jeff Bezos-founded space company conducted a mostly successful test flight of its 320-foot-tall New Glenn rocket
By Peter Weber, The Week US Published
-
US won its war on 'murder hornets,' officials say
Speed Read The announcement comes five years after the hornets were first spotted in the US
By Peter Weber, The Week US Published
-
Dark energy data suggest Einstein was right
Speed Read Albert Einstein's 1915 theory of general relativity has been proven correct, according to data collected by the Dark Energy Spectroscopic Instrument
By Peter Weber, The Week US Published
-
New DNA tests of Pompeii dead upend popular stories
Speed Read An analysis of skeletal remains reveals that some Mount Vesuvius victims have been wrongly identified
By Peter Weber, The Week US Published